We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues showed moderate granular cytoplasmic immunoreactivity. Several breast carcinomas and liver cancers displayed strong positivity. The majority of testicular, endometrial, cervical, lung, renal and head & neck cancers were negative.
Q9Y2X0 [Direct mapping] Mediator of RNA polymerase II transcription subunit 16
Show all
MEMSAT3 predicted membrane proteins SPOCTOPUS predicted membrane proteins THUMBUP predicted membrane proteins Predicted intracellular proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003712 [transcription cofactor activity] GO:0003713 [transcription coactivator activity] GO:0003824 [catalytic activity] GO:0004872 [receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0010467 [gene expression] GO:0016020 [membrane] GO:0016592 [mediator complex] GO:0030375 [thyroid hormone receptor coactivator activity] GO:0030518 [intracellular steroid hormone receptor signaling pathway] GO:0030521 [androgen receptor signaling pathway] GO:0042809 [vitamin D receptor binding] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0046966 [thyroid hormone receptor binding] GO:2000273 [positive regulation of receptor activity]